40 related articles for article (PubMed ID: 1687191)
1. Effect of L-dopa and reserpine on in vivo binding of (3H)-SCH 23390 and (3H)-N-methylspiperone.
Yonezawa H; Inoue O; Tsukada H; Suhara T; Itoh T; Tohgi H; Yamasaki T; Långström B
Acta Radiol Suppl; 1991; 376():167-8. PubMed ID: 1687191
[No Abstract] [Full Text] [Related]
2. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B
Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566
[TBL] [Abstract][Full Text] [Related]
3. Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain.
Inoue O; Kobayashi K; Tsukada H; Itoh T; Langstrom B
J Neural Transm Gen Sect; 1991; 85(1):1-10. PubMed ID: 1678266
[TBL] [Abstract][Full Text] [Related]
4. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.
Rubinstein M; Muschietti JP; Gershanik O; Flawia MM; Stefano FJ
J Pharmacol Exp Ther; 1990 Feb; 252(2):810-6. PubMed ID: 2138223
[TBL] [Abstract][Full Text] [Related]
5. Dopamine receptor changes in response to prolonged treatment with L-dopa.
Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
[TBL] [Abstract][Full Text] [Related]
6. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Alachkar A; Brotchie JM; Jones OT
Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
[TBL] [Abstract][Full Text] [Related]
7. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of dopamine depletion on the distribution of [3H]SCH 23390 and [3H]spiperone binding sites in the goldfish retina.
Yazulla S; Lin ZS
Vision Res; 1995 Sep; 35(17):2409-14. PubMed ID: 8594810
[TBL] [Abstract][Full Text] [Related]
9. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
Chugani DC; Ackermann RF; Phelps ME
J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803
[TBL] [Abstract][Full Text] [Related]
10. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
11. Effect of repeated administration of U-50,488H on the binding of 3H-SCH 23390 and 3H-spiperone to rat brain and spinal cord dopamine receptors.
Bhargava HN; Ramarao P; Gulati A
Prog Clin Biol Res; 1990; 328():153-6. PubMed ID: 2406759
[No Abstract] [Full Text] [Related]
12. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats.
Wardas J
Pol J Pharmacol; 2003; 55(2):155-64. PubMed ID: 12926542
[TBL] [Abstract][Full Text] [Related]
15. Differential localization of dopamine D1 and D2 receptors in rat retina.
Tran VT; Dickman M
Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
[TBL] [Abstract][Full Text] [Related]
16. Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice.
Rice OV; Gatley SJ; Shen J; Huemmer CL; Rogoz R; DeJesus OT; Volkow ND; Gifford AN
Neuropsychopharmacology; 2001 Nov; 25(5):679-89. PubMed ID: 11682251
[TBL] [Abstract][Full Text] [Related]
17. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
[TBL] [Abstract][Full Text] [Related]
18. Effect of lithium and anesthetics on in vivo binding of dopamine receptors.
Inoue O; Tsukada H; Suhara T; Yonezawa H; Itoh T; Yamasaki T
Acta Radiol Suppl; 1991; 376():123. PubMed ID: 1666744
[No Abstract] [Full Text] [Related]
19. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats.
Lee J; Di Marzo V; Brotchie JM
Neuropharmacology; 2006 Sep; 51(3):557-65. PubMed ID: 16806299
[TBL] [Abstract][Full Text] [Related]
20. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
